| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |